完全再灌注相较于成功再灌注的获益随时间推移而减少
该研究基于法国21个中心的前瞻性观察性多中心登记(Endovascular Treatment in Ischemic Stroke),分析4444例前循环闭塞且症状发作时间已知的急性缺血性卒中患者,比较mTICI 2c-3与2b再灌注的预后差异。结果显示,再灌注时间1小时时,mTICI 2c-3较2b的早期神经功能改善和90天良好预后边际概率更高,但获益随再灌注时间延长而逐渐下降,超过414分钟(早期改善)和344分钟(良好预后)后差异不再显著。
要点
- 再灌注时间1小时时,mTICI 2c-3较2b的早期神经功能改善边际概率高25.6%(95%CI 11.7-39.5),良好预后边际概率高15.2%(95%CI 3.0-27.4)。
- mTICI 2c-3相较2b的获益随再灌注时间延长而逐渐下降。
- 再灌注时间超过414分钟和344分钟后,早期神经功能改善和良好预后的差异分别不再显著。
核心结论
- 完全再灌注相较于成功再灌注的预后价值随时间推移而逐渐下降,再灌注时间超过5.7小时后,完全再灌注与成功再灌注在良好预后率上无差异。
研究设计与样本
- 前瞻性、观察性、多中心研究,数据来自法国21个中心的Endovascular Treatment in Ischemic Stroke登记。
- 共纳入4444例前循环闭塞(M1、颈内动脉、串联闭塞)且症状发作时间已知的急性缺血性卒中患者,均接受血管内治疗。
主要发现
- 再灌注时间1小时时,mTICI 2c-3较mTICI 2b的早期神经功能改善平均边际概率高25.6%(95%CI 11.7-39.5,p=0.0003),良好预后平均边际概率高15.2%(95%CI 3.0-27.4,p=0.0143)。
- mTICI 2c-3相较mTICI 2b的获益随再灌注时间延长而逐渐下降。
- 再灌注时间超过414分钟后,mTICI 2c-3与mTICI 2b在早期神经功能改善率上的差异不再显著。
- 再灌注时间超过344分钟后,mTICI 2c-3与mTICI 2b在良好预后率上的差异不再显著。
关键数值与推荐
- 再灌注状态采用mTICI分级:mTICI 2c-3为接近完全或完全再灌注,mTICI 2b为成功再灌注。
- 早期神经功能改善定义为24小时评估,良好预后定义为90天改良Rankin量表评分0-2分。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Time from stroke onset to reperfusion (TSOR) is strongly associated with outcomes after endovascular treatment. A near-to-complete or complete reperfusion (modified Treatment in Cerebral Ischemia [mTICI] 2c-3) is associated with improved outcomes compared with a successful reperfusion (mTICI 2b). However, it is unknown whether this association remains stable as TSOR increases. Therefore, we sought to investigate the association between TSOR and outcomes according to the reperfusion status. METHODS: We analyzed data from the Endovascular Treatment in Ischemic Stroke registry, a prospective, observational, multicentric study of acute ischemic stroke patients treated with endovascular treatment in 21 centers in France. We included patients with anterior occlusions (M1, internal carotid artery, tandem), with a known time of symptom onset. Outcomes were early neurological improvement at 24 hours and favorable outcome (modified Rankin Scale between 0 and 2) at 90 days. RESULTS: Overall, 4,444 patients were analyzed. Compared with a mTICI 2b, a mTICI 2c-3 at 1 hour was associated with higher mean marginal probabilities of early neurological improvement (25.6%, 95% CI 11.7-39.5, p = 0.0003) and favorable outcome (15.2%, 95% CI 3.0-27.4, p = 0.0143), and progressively declined with TSOR. The benefit of a mTICI 2c-3 over a mTICI 2b was no longer significant regarding the rates of early neurological improvement and favorable outcome after a TSOR of 414 and 344 minutes, respectively. INTERPRETATION: The prognostic value of a complete over a successful reperfusion progressively declined with time, and no difference regarding the rates of favorable outcome was observed between a complete and successful reperfusion beyond 5.7 hours. ANN NEUROL 2023;93:934-941.
引用
- Maïer B, Finitsis S, Mazighi M, et al. The Benefit of a Complete over a Successful Reperfusion Decreases with Time. Ann Neurol. 2023. PMID: 36640043. doi:10.1002/ana.26599
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。